174 related articles for article (PubMed ID: 34581754)
1. Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution.
Maurer K; Kim HT; Kuczmarski TM; Garrity HM; Weber A; Reynolds CG; Liney D; Cutler C; Antin JH; Koreth J; Ritz J; Shapiro RM; Romee R; Wu CJ; Soiffer RJ; Nikiforow S; Ho VT; Gooptu M
Blood Adv; 2021 Dec; 5(23):5140-5149. PubMed ID: 34581754
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic.
Hsu JW; Farhadfar N; Murthy H; Logan BR; Bo-Subait S; Frey N; Goldstein SC; Horowitz MM; Lazarus H; Schwanke JD; Shah NN; Spellman SR; Switzer GE; Devine SM; Shaw BE; Wingard JR
Transplant Cell Ther; 2021 Jun; 27(6):507-516. PubMed ID: 33865804
[TBL] [Abstract][Full Text] [Related]
3. Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes.
Keyzner A; Azzi J; Jakubowski R; Sinitsyn Y; Tindle S; Shpontak S; Kwon D; Isola L; Iancu-Rubin C
Transplant Proc; 2023 Oct; 55(8):1799-1809. PubMed ID: 37210273
[TBL] [Abstract][Full Text] [Related]
4. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C
Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721
[TBL] [Abstract][Full Text] [Related]
5. Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report.
Bankova AK; Caveney J; Yao B; Ramos TL; Bögeholz J; Heydari K; Diaz N; Jackson ML; Lowsky R; Brown JW; Johnston L; Rezvani AR; Frank MJ; Muffly L; Weng WK; Sidana S; Negrin RS; Miklos DB; Shiraz P; Meyer EH; Shizuru JA; Arai S
Transplant Cell Ther; 2022 Apr; 28(4):215.e1-215.e10. PubMed ID: 35042013
[TBL] [Abstract][Full Text] [Related]
6. Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
Connelly-Smith L; Gooley T; Roberts L; Mielcarek M; Linenberger M; Petersdorf E; Sandmaier BM; Milano F
Transplant Cell Ther; 2023 Nov; 29(11):700.e1-700.e8. PubMed ID: 37659695
[TBL] [Abstract][Full Text] [Related]
7. Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 pandemic: a single center experience.
Guo M; Liu J; Clark P; Ahmad S; Patel R; Varela JC; Mori S
Int J Hematol; 2023 Mar; 117(3):428-437. PubMed ID: 36378406
[TBL] [Abstract][Full Text] [Related]
8. Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program.
Kanda Y; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Kodera Y
Transplant Cell Ther; 2021 Aug; 27(8):664.e1-664.e6. PubMed ID: 33964514
[TBL] [Abstract][Full Text] [Related]
9. Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
Fernandez-Sojo J; Azqueta C; Valdivia E; Martorell L; Medina-Boronat L; Martínez-Llonch N; Torrents S; Codinach M; Canals C; Elorza I; Parody R; Martino R; Trabazo M; Díaz de Heredia C; Ferra C; Valcárcel D; Linares M; Ancochea Á; García-Rey E; García-Muñoz N; Medina L; Castillo N; Carreras E; Villa J; Querol S
Bone Marrow Transplant; 2021 Oct; 56(10):2489-2496. PubMed ID: 34127808
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic.
Devine SM; Bo-Subait S; Kuxhausen M; Spellman SR; Bupp C; Ahn KW; Stefanski HE; Auletta JJ; Logan BR; Shaw BE
Blood Adv; 2023 Oct; 7(19):5982-5993. PubMed ID: 37036959
[TBL] [Abstract][Full Text] [Related]
11. Effect of Cryopreservation in Unrelated Bone Marrow and Peripheral Blood Stem Cell Transplantation in the Era of the COVID-19 Pandemic: An Update from the Japan Marrow Donor Program.
Kanda Y; Doki N; Kojima M; Kako S; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Atsuta Y; Kodera Y
Transplant Cell Ther; 2022 Oct; 28(10):677.e1-677.e6. PubMed ID: 35803526
[TBL] [Abstract][Full Text] [Related]
12. The Viability of Hematopoietic Progenitor Cell Grafts after Cryopreservation Does Not Predict Delayed Engraftment in Allogeneic Hematopoietic Stem Cell Transplantation.
Fadeyi E; Mamo YT; Saha AK; Wilson E; Pomper G
Lab Med; 2022 Sep; 53(5):509-513. PubMed ID: 35640044
[TBL] [Abstract][Full Text] [Related]
13. Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registry.
Bekadja MA; Boumendil A; Blaise D; Chevallier P; Peggs KS; Salles G; Giebel S; Marks R; Arcese W; Milpied N; Finel H; Gorin NC
Cytotherapy; 2021 Jun; 23(6):483-487. PubMed ID: 33678598
[TBL] [Abstract][Full Text] [Related]
14. Fresh vs. frozen allogeneic peripheral blood stem cell grafts: A successful timely option.
Alotaibi AS; Prem S; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Mattsson J; Michelis FV
Am J Hematol; 2021 Feb; 96(2):179-187. PubMed ID: 33108034
[TBL] [Abstract][Full Text] [Related]
15. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM.
Lioznov M; Dellbrügger C; Sputtek A; Fehse B; Kröger N; Zander AR
Bone Marrow Transplant; 2008 Jul; 42(2):121-8. PubMed ID: 18391988
[TBL] [Abstract][Full Text] [Related]
16. Non-cryopreserved peripheral blood stem cells as a safe and effective alternative for autologous transplantation in multiple myeloma.
Araújo AB; Soares TB; Schmalfuss T; Angeli MH; Furlan JM; Salton GD; Burin MM; Röhsig LM
Transfusion; 2022 Oct; 62(10):1967-1972. PubMed ID: 36052689
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Cryopreservation on Hematopoietic Stem Cell Engraftment and Post-transplant Outcome During the COVID-19 Pandemic.
Strzelec A; Gawlik-Rzemieniewska N; Klima A; Panek K; Helbig G
In Vivo; 2024; 38(3):1271-1277. PubMed ID: 38688614
[TBL] [Abstract][Full Text] [Related]
18. Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program.
Farhadfar N; Newman J; Novakovich J; Barten J; Ndifon ET; Oakes J; Cody M; Pham HP; Auletta JJ; Miller JP; Devine SM; Stefanski HE
Front Immunol; 2022; 13():937900. PubMed ID: 36203566
[TBL] [Abstract][Full Text] [Related]
19. Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts.
Novitzky-Basso I; Remberger M; Chen C; Pasić I; Lam W; Law A; Gerbitz A; Viswabandya A; Lipton JH; Kim DD; Kumar R; Mattsson J; Michelis FV
Eur J Haematol; 2022 Jan; 108(1):61-72. PubMed ID: 34606661
[TBL] [Abstract][Full Text] [Related]
20. CD34+ Stem Cell Selection and CD3+ T Cell Add-Back from Matched Unrelated Adult Donors in Children with Primary Immunodeficiencies and Hematological Diseases.
Porta F; Comini M; Soncini E; Carracchia G; Maffeis M; Pintabona V; Bolda F; Beghin A; Schumacher RF; Lanfranchi A
Transplant Cell Ther; 2021 May; 27(5):426.e1-426.e9. PubMed ID: 33965183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
